Our qualified US Licensed Providers prioritize your well-being, providing top-quality care
BEACON CRC (binimetinib [BINI], encorafenib [ENCO], and cetuximab [CTX] combined to treat BRAF-mutant metastatic colorectal cancer [mCRC]): A multicenter, randomized, open-label, three-arm phase III study of ENCO plus CTX plus or minus BINI vs irinotecan (IRI)/CTX or infusional 5-fluorouracil/folinic acid/IRI (FOLFIRI)/CTX with a safety lead-in of ENCO + BINI + CTX in patients (Pts) with BRAFV600E mCRC
Using a diluent with a substantially different preservative concentration, or substituting an unrelated solvent, can introduce unpredictable interactions with the peptide's amino acid side chains
Light, Clean, Caffeine-Free: Steel Burn is calorie-free, sugar-free, and carbohydrate-free